ATX-01
/ ARTHEx Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
January 22, 2026
ArthemiR: Study of ATX-01 in Participants With DM1
(clinicaltrials.gov)
- P1/2 | N=56 | Recruiting | Sponsor: ARTHEx Biotech S.L. | Trial completion date: Jun 2026 ➔ Jul 2027 | Trial primary completion date: Jun 2026 ➔ Jul 2027
Trial completion date • Trial primary completion date • Genetic Disorders • Muscular Dystrophy • Myotonic Dystrophy
February 28, 2025
ArthemiR: Study of ATX-01 in Participants with DM1
(clinicaltrials.gov)
- P1/2 | N=56 | Recruiting | Sponsor: ARTHEx Biotech S.L. | Trial completion date: Dec 2025 ➔ Jun 2026 | Trial primary completion date: Dec 2025 ➔ Jun 2026
Trial completion date • Trial primary completion date • Genetic Disorders • Muscular Dystrophy • Myotonic Dystrophy
June 06, 2024
ArthemiR: Study of ATX-01 in Participants With DM1
(clinicaltrials.gov)
- P1/2 | N=56 | Recruiting | Sponsor: ARTHEx Biotech S.L. | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Muscular Dystrophy • Myotonic Dystrophy
March 12, 2024
ArthemiR: Study of ATX-01 in Participants With DM1
(clinicaltrials.gov)
- P1/2 | N=56 | Not yet recruiting | Sponsor: ARTHEx Biotech S.L.
New P1/2 trial • Genetic Disorders • Muscular Dystrophy • Myotonic Dystrophy
1 to 4
Of
4
Go to page
1